Article Excerpt: In a 2025 clinical trial involving 106 adults, Dartmouth researchers found significant symptom improvements among participants using a purpose-built generative AI mental health chatbot, including a 51% average reduction among participants with depression and 31% among those with generalized anxiety. The findings came from a single study of this specific system and should not be generalized to consumer AI chatbots.
But even with those results, study author Michael Heinz said no generative AI agent is ready to operate fully on its own in mental health, leaving a lot of important questions about safety and reliability unresolved.
Full Article: https://tinyurl.com/4ke2esn2
Article Source: The Good Men Project. Also published in The Roanoke Times.